神经保护
医学
缺血
脂质体
药理学
冲程(发动机)
脑缺血
血脑屏障
组织纤溶酶原激活剂
麻醉
中枢神经系统
内科学
化学
生物化学
机械工程
工程类
作者
Tatsuya Fukuta,Takayuki Ishii,Tomohiro Asai,Akihiko Sato,Takashi Kikuchi,Kosuke Shimizu,Tohru Minamino,Naoto Oku
标识
DOI:10.1016/j.ejpb.2015.09.020
摘要
Since the proportion of patients given thrombolytic therapy with tissue plasminogen activator (t-PA) is very limited because of the narrow therapeutic window, the development of new therapies for ischemic stroke has been desired. We previously reported that liposomes injected intravenously accumulate in the ischemic region of the brain via disruption of the blood–brain barrier that occurs under cerebral ischemia. In the present study, we investigated the efficacy of a liposomal neuroprotective agent in middle cerebral artery occlusion (MCAO) rats to develop ischemic stroke therapy prior to the recovery of cerebral blood flow. For this purpose, PEGylated liposomes encapsulating FK506 (FK506-liposomes) were prepared and injected intravenously into MCAO rats after a 1-h occlusion. This treatment significantly suppressed the expansion of oxidative stress and brain cell damage. In addition, administration of FK506-liposomes before reperfusion significantly ameliorated motor function deficits of the rats caused by ischemia/reperfusion injury. These findings suggest that FK506-liposomes effectively exerted a neuroprotective effect during ischemic conditions, and that combination therapy with a liposomal neuroprotectant plus t-PA could be a promising therapeutic strategy for ischemic stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI